NCT00924248View on ClinicalTrials.gov

Primovist Regulatory Post Marketing Surveillance (PMS)

CompletedOBSERVATIONAL
Enrollment

4,358

Participants

Timeline

Start Date

October 31, 2007

Study Completion Date

May 31, 2011

Conditions
Liver
Interventions
DRUG

Gadoxetic acid disodium (Primovist, BAY86-4873)

Patients in daily life clinical practice treatment receiving Primovist according to indication on the label.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00924248 - Primovist Regulatory Post Marketing Surveillance (PMS) | Biotech Hunter | Biotech Hunter